In this study, bioinformatic and IHC analyses revealed that CCL20 was aberrantly elevated in tumour tissues compared with the normal tissues, and highly expressed CCL20 resulted in low OS, PFI and DSS rates (Fig. 6). The gene discussed is CCL20; the disease is neoplasm.